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Investigating the impact of the diseases of despair in Appalachia
Abstract
Introduction: Appalachia is one of the regions most significantly impacted by the opioid crisis. This study
investigated mortality due to diseases of despair within the Appalachian Region, with an additional focus
on deaths attributable to opioid overdose.
Methods: Diseases of despair include: alcohol, prescription drug and illegal drug overdose, suicide, and
alcoholic liver disease/cirrhosis of the liver. Mortality data from the National Center for Health Statistics
(NCHS) National Vital Statistics System (NVSS) Multiple Cause of Death database were analyzed for this
study, focusing on individuals aged 15–64.
Results: Over the past two decades, the mortality rate due to diseases of despair has been increasing
across the United States, but the gap has widened between the Appalachian Region and the rest of the
nation. In 2017, the combined diseases of despair mortality rate was 45% higher in the Appalachian
Region than the non-Appalachian United States. When looking at just overdose mortality, this disparity
grows to 65% higher in the Appalachian Region. Within the Appalachian region disparities are most
notable in the Central and North Central Appalachian subregions, among males, and among individuals
age 45 to 54.
Discussion: These findings document the scale and scope of the problem in Appalachia and highlight the
need for additional research and discussion in terms of effective interventions, policies, and strategies to
address these diseases of despair. Over the past two decades, mortality from overdose, suicide, and
alcoholic liver diseases/cirrhosis has increased across the United States, but the disparity between
Appalachia and the non-Appalachian U.S. continues to grow.
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INTRODUCTION

T

he Appalachian Region is a 205,000-square-mile region that spans from
southern New York to northern Mississippi, includes 420 counties and 8
independent cities in 13 states, and has a population of 25 million people
(Figure 1).1 Appalachia lags behind the rest of the nation in educational
attainment, economic development, and health outcomes.2,3 Appalachia’s
median household income is 83% of the U.S. average, and the region’s poverty
rate is 16%.2,4 Certain Appalachian subregions experience greater disparities
than others; for example, labor force participation, household income, and
bachelor’s degree attainment are lowest in Central Appalachia.2,4–6 A number of
studies have shown that the residents of the Appalachian Region experience
significant health disparities compared to the rest of the nation.3,7–10

Figure 1. Map of the Appalachian Region
Research conducted by Case and Deaton has demonstrated increasing morbidity
and mortality from three main causes—alcohol, prescription drug and illegal
drug overdose; suicide; and alcoholic liver disease/cirrhosis of the liver—which
have been referred to collectively as “diseases of despair.”11 The rise in overdose
mortality described by Case and Deaton was driven by the opioid crisis in the
U.S. According to data from the Centers for Disease Control and Prevention
(CDC), in 2017, the number of overdose deaths involving opioids was six times
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higher than in 1999.12 Socioeconomic factors, including education, employment,
and income, are potential factors influencing the growing opioid crisis in the U.S.
This study investigated mortality due to diseases of despair within the
Appalachian Region, with an additional focus on deaths attributable to opioid
overdose.
METHODS
This study aimed to detect differences in the mortality rates from diseases of
despair between the Appalachian Region and the non-Appalachian U.S. (the rest
of the country, excluding Appalachia), in addition to differences by age groups
and gender. Appalachian rates were further analyzed by subregion, county
economic status, and levels of rurality. Appalachian subregions, as defined by
the Appalachian Regional Commission (ARC), represent contiguous geographies
of relatively homogeneous characteristics (topography, demographics,
economics, and transportation) and include: Northern, North Central, Central,
South Central, and Southern Appalachia. ARC also provides county-level
economic classifications based on an index of three economic indicators (3-year
unemployment rate, per capita market income, and poverty rate). Counties are
designated based on the index as distressed, at-risk, transitional, competitive,
or attainment.13 Lastly, ARC designations for rurality were used for these
analyses. These designations of large metro, small metro, nonmetro adjacent to
large metros, nonmetro counties adjacent to small metros, and rural counties
are based on a simplification of the UDSA’s Economic Research Services (ERS)
2013 Urban Influence Codes (UIC).14
The majority of the findings presented are from 2015 mortality data from the
National Center for Health Statistics (NCHS) National Vital Statistics System
(NVSS) Multiple Cause of Death database, accessed through the CDC Wideranging Online Data for Epidemiologic Research (CDC WONDER).15 Select
findings include data through 2017. The Multiple Cause of Death database
provides the underlying cause-of-death, as well as up to 20 additional multiple
causes, as reported on an individual’s death certificate by a physician, coroner,
and/or medical examiner.16 Deaths are coded to the International Classification
of Disease Tenth Revision (ICD-10) codes.
These analyses included the ICD-10 codes referenced by Case and Deaton,
reflecting the underlying cause of death from each of the three diseases of
despair: alcohol, prescription drug and illegal drug overdose (X40–X45, Y10–Y15,
Y45–Y49); suicide (Y87.0, X60–X84); and alcoholic liver disease/cirrhosis of the
liver (K70, K73–K74).11 Multiple cause-of-death ICD-10 codes (T40.0, T40.1,
T40.2, T40.3, T40.4, T40.6) that specify the type of drug causing the overdose
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were used to determine the percentage of alcohol, prescription drug and illegal
drug overdose deaths attributed to opioids.17
The findings present age-adjusted mortality rates for the population aged 15 to
64. Additional analyses provide a more granular focus on mortality rates by age
group (10-year increments between ages 15 and 64). Statistical significance was
assessed at the 0.05 level using two-sided significance tests (z-tests).
RESULTS
Over the past 2 decades, the mortality rate due to diseases of despair has been
increasing across the U.S. While the non-Appalachian U.S. has seen a rise in
these deaths, the gap has widened between the Appalachian Region and the rest
of the nation. As shown in Figure 2, the combined diseases of despair mortality
rate in Appalachia and the non-Appalachian U.S. were nearly identical in 1999.
By 2009, the mortality rate in the Appalachian Region was 24% higher than the
non-Appalachian U.S., and by 2017, this difference had grown to 45%. Between
2009 and 2017, the rate in Appalachia has nearly tripled, showing the increasing
burden associated with these diseases of despair.
82.5

33.3

41.2
34.3

30
1999

48.3
39.1

56.8

57.0
43.5

2004

2009

2014

Appalachia

Non-Appalachian U.S.

Figure 2. Annual mortality rates attributable to diseases of despair, ages
15–64, by region (1999–2017)*‡
‡Rates are presented as deaths per 100,000 population. Rates are age adjusted.
*In all years except 1999, the Appalachian rate is significantly different from the nonAppalachian U.S. rate, p ≤0.05
Source: Mortality Rates and Standard Errors provided by Centers for Disease Control and
Prevention, National Center for Health Statistics.
Accessed at http://wonder.cdc.gov/mcd-icd10.html

As shown in Figure 3, the mortality rate in 2017 for the combined diseases of
despair among those aged 15 to 64 years was 82.5 deaths per 100,000
population, compared to 57.0 deaths per 100,000 population for the non-
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Appalachian U.S. Among the three causes of death (overdose, suicide, and
alcoholic liver disease/cirrhosis), the disparity between Appalachia and the nonAppalachian U.S. was greatest for overdose deaths. In 2017, the overdose
mortality rate was 65% higher in Appalachia than in the non-Appalachian U.S.
(48.3 deaths per 100,000 population in Appalachia compared to 29.2 deaths per
100,000 population in the rest of the U.S.) The suicide mortality rate was 30%
higher in Appalachia, and the alcoholic liver disease/cirrhosis mortality rate was
10% higher.

Figure 3. Diseases of despair mortality rates, ages 15–64, by disease and
region (2017)*‡
‡Rates are presented as deaths per 100,000 population. Rates are age adjusted.
*For all diseases, the Appalachian rate is significantly different from the non-Appalachian U.S.
rate, p ≤0.05
Source: Mortality Rates and Standard Errors provided by Centers for Disease Control and
Prevention, National Center for Health Statistics. Accessed at http://wonder.cdc.gov/mcdicd10.html

The remaining findings are based on 2015 mortality data. As shown in Table 1,
within Appalachia, males were more likely than females to die from overdose,
suicide, and alcoholic liver disease/cirrhosis. Among males, the mortality rate
for the diseases of despair was 92.7 deaths per 100,000, compared to 41.8
deaths per 100,000 for females. Within Appalachia, individuals aged 45 to 54
had the highest mortality rate from the combined diseases of despair in 2015, at
89.0 deaths per 100,000 population.
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Certain subregions of Appalachia face a notable disparity in mortality from
overdose, suicide, and alcoholic liver disease/cirrhosis. The mortality rates due
to the combined diseases of despair were highest in Central and North Central
Appalachia, with rates of 94.4 deaths per 100,000 population and 88.6 deaths
per 100,000, respectively. In comparison, the mortality rates in Northern, South
Central, and Southern Appalachia were 69.1, 65.1, and 52.3 deaths per 100,000,
respectively.
Mortality rates also differed by county economic status. For the combined
diseases of despair, the mortality rate was highest for distressed counties, at
83.6 deaths per 100,000 population, compared to 47.2 deaths per 100,000
population for attainment counties. Competitive counties had the second highest
mortality rate for the combined diseases of despair (73.1 deaths per 100,000
population.)
For the combined diseases of despair, rural counties had the highest mortality
rate at 70.5 deaths per 100,000, compared to 63.2 deaths per 100,000 for large
metro counties.
Overdose Deaths. Overdose deaths have become increasingly common over the
past decade, largely due to the opioid crisis, which has greatly impacted
Appalachia. In the Appalachian Region in 2015, there were 5594 overdose deaths
among those aged 15 to 64 years, and of these, 69% were caused by opioids
(opium, heroin, methadone, other opioids and synthetic narcotics). Overdose
mortality was 34% higher in economically distressed counties than economically
nondistressed (attainment, competitive, transitional, and at-risk) counties.
When comparing metro (large metro and small metro) and nonmetro (nonmetro,
adjacent large metro; nonmetro, adjacent small metro; and rural) counties, the
difference was less notable—the overdose mortality rate in metro counties was
6% higher than the rate in nonmetro counties.
Overdose mortality significantly impacts Appalachian adults between the ages of
25 and 54. Among males, the burden in Appalachia was the greatest among
those aged 25 to 34 years (61.9 deaths per 100,000 population) and 35 to 44
years (61.0 deaths per 100,000 population). These age groups also experienced
the highest mortality rates in the non-Appalachian U.S., though large disparities
were observed when comparing Appalachia to the non-Appalachian U.S.
Specifically, the overdose mortality rate was 78% higher among those ages 35 to
44 years and 72% higher among those aged 25 to 34 years in Appalachia than
the non-Appalachian U.S. While the overall burden was lower among females
than males, the disparity between Appalachia and the non-Appalachian U.S. was
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Table 1. Diseases of Despair mortality rates, ages 15–64 (2015)‡

Region
Appalachia
Non-Appalachian U.S.
Appalachian Subregion
Northern
North Central
Central
South Central
Southern
Economic Status in
Appalachia
Distressed
Non-Distressed
At-Risk
Transitional
Competitive
Attainment
Rurality (within Appalachia)
Large Metro
Small Metro
Nonmetro, adjacent Large
Metro
Nonmetro, adj Small
Metro
Rural
Gender (within Appalachia)
Male
Female
Age Group (within
Appalachia)
15–24
25–34
35–44
45–54
55–64

Overdose

Suicide

Alcoholic
liver
disease/
cirrhosis

Combined
Despair
Deaths

35.4
21.5

19.8
16.5

11.4
10.6

66.6
48.6

40.2
56.3
54.9
30.7
22.7

19.7
19.4
23.3
21.1
18.5

9.3
11.3
16.2
13.3
11.0

69.1
88.6
94.4
65.1
52.3

46.2

22.1

15.4

83.6

33.1
33.7
45.8
26.4

22.9
19.4
17.5
15.2

15.2
10.7
9.9
--

71.2
63.7
73.1
47.2

37.2
35.5
33.6

17.2
19.8
21.1

8.8
12.3
11.9

63.2
67.5
66.7

32.4

22.4

12.1

66.9

36.2

21.2

13.2

70.5

45.1
25.6

31.1
8.5

16.0
7.0

92.2
41.1

12.3
44.5
47.8
42.7
23.2

12.6
19.4
21.9
24.5
20.7

-1.7
8.3
21.8
34.5

24.9
65.7
78.0
89.0
78.4

‡Rates are presented as deaths per 100,000 population. Rates are age adjusted.
Source: Mortality Rates and Standard Errors provided by Centers for Disease Control and Prevention,
National Center for Health Statistics.
Accessed at http://wonder.cdc.gov/mcd-icd10.html
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greater for females than for males. Among females, the burden in Appalachia
was the greatest among those aged 45 to 54 years (35.8 deaths per 100,000
population) and 35 to 44 years (34.7 deaths per 100,000 population). The
overdose mortality rate for Appalachian females ages 35 to 44 was more than
double the rate for females in the non-Appalachian U.S., and among those aged
25 to 34 years, the Appalachian rate was 92% higher.
As shown in Table 2, states within Appalachia differ in terms of the burden of
overdose mortality, and also in the percentage of overdose deaths that were
opioid-related. West Virginia had both the highest overdose mortality rate (59.7
deaths per 100,000) and the largest percentage of deaths attributed to opioids,
at 88%. In contrast, Appalachian Mississippi had an overdose mortality rate of
12.9 deaths per 100,000, of which only 34% were caused by opioids. The greatest
burden from overdose is located within the states of Central and North Central
Appalachia, specifically, West Virginia, Appalachian Kentucky, and Appalachian
Ohio.
LIMITATIONS
There are several limitations to this study. First, while we highlight the
significant increase in overdose deaths between 2015 and 2017, the analyses
presented for subgroups, including age, gender, economic status, and rurality,
are based on 2015 mortality data. Due to the rapidly evolving nature of the opioid
crisis in the U.S., some of these differences have likely changed since 2015.
Secondly, because we conducted analyses for the diseases of despair
individually, suicides that are attributable to opioids are not included in the
overdose category. Finally, the data on opioid-related overdoses are based on
death certificate reporting, and there are known variations by state in terms of
the quality of this data.
DISCUSSION
These findings document the scale and scope of the problem in Appalachia and
highlight the need for additional research and discussion in terms of effective
interventions, policies, and strategies to address these diseases of despair. Over
the past two decades, mortality from overdose, suicide, and alcoholic liver
diseases/cirrhosis has increased across the U.S., but the disparity between
Appalachia and the non-Appalachian U.S. continues to grow. Within Appalachia,
the burden is concentrated within the Central and North Central subregions,
where the majority of economically distressed counties are located. Economic
development strategies and interventions that address other underlying
contributors to the diseases of despair, in addition to increased access to
treatment services, prevention, and overdose medications, may be important
considerations in addressing this problem.
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Table 2. Overdose and opioid-related overdose mortality rates, ages 15–
64, by state^ (2015)‡
Overdose
Alabama
Georgia
Kentucky
Maryland
Mississippi
New York
North Carolina
Ohio
Pennsylvania
South Carolina
Tennessee
Virginia
West Virginia
Appalachia
Non-Appalachian
U.S.

24.7
19.8
52.1
48.4
12.9
24.3
31.7
49.1
42.0
30.8
33.9
26.1
59.7
35.4
21.5

*
*
*
*
*
*
*
*
*
*
*

Opioid-related
Overdose
10.8 *
14.4
38.5 *
41.4 *
4.4 †
17.2 *
25.2 *
40.5 *
24.7 *
22.4 *
24.0 *
19.6 *
52.8 *
24.6 *
16.5

Percent Opioidrelated (%)
44
73
74
86
34
71
79
82
59
73
71
75
88
69
64

^For states within Appalachia, only the mortality rate for the Appalachian counties is shown.
‡Rates are presented as deaths per 100,000 population. Rates are age adjusted.
*Mortality rate is significantly different than the non-Appalachian U.S. rate for the same
overdose category, p ≤0.05
†Due to small number of deaths, opioid mortality rate is unreliable and not age adjusted.
Source: Mortality Rates and Standard Errors provided by Centers for Disease Control and
Prevention, National Center for Health Statistics.
Accessed at http://wonder.cdc.gov/mcd-icd10.html

The rise in opioid overdoses over the past several years has contributed to some
of the recent increases in diseases of despair. The states with the highest
mortality from overdose in the Appalachian Region are the ones most
significantly impacted by the opioid crisis, as shown by the large percentage of
overdose deaths attributed to opioids. When comparing Appalachia to the nonAppalachian U.S., the most notable disparities in overdose deaths existed for the
group aged 25–44 years. Young adults in Appalachia are considerably more likely
to die from an overdose than similar-aged adults in the rest of the U.S., which
has significant implications, particularly in terms of economic development, as
individuals in their prime working years are most impacted.
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The 2017 data presented shows the rapid increase in overdose deaths due to the
more powerful synthetic opioids, such as fentanyl; however, these rates have
likely continued to rise, and the burden within the Appalachian Region is likely
greater than described in these findings. It is critical to continue to track trends
in diseases of despair, and particularly opioid-related mortality, to assess the
growing burden related to fentanyl and other synthetic opioids.
SUMMARY BOX
What is already known about this topic? Work conducted by Case and Deaton (2015)
demonstrated disparities in mortality resulting from overdose, suicide, and alcoholic liver
disease among Caucasian working age adults, collectively termed diseases or deaths of
despair.
What is added by this report? The work described in this paper expands upon that of Case
and Deaton by providing a focused exploration of diseases of despair within the Appalachian
region. Findings confirm those of Case and Deaton and provide evidence of disparities
focused most prominently within the Central and North Central Appalachian subregions.
What are the implications for public health practice, policy, and research? Beyond
direct implications related to greater mortality burden within the population of working age
adults in the Central and North Central Appalachian subregions, diseases of despair have
cascading impacts on regional economic development, children’s health and well-being, and
social support systems, among others. Increasing access to treatment services, harm
reduction programs and prevention initiatives will benefit individuals with substance use
disorder and provide broader community benefit as rates of substance misuse and overdose
decline. More broadly, understanding differences in mortality rates at the subregion and
population group levels support resource allocation and response efforts.
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